|
|
| April 4, 2011: Dr. Gregg Stone and Dr. C. Michael Gibson discuss: A Prospective, Randomized, Investigation of a Novel Platinum Chromium |
Dr. Gregg Stone and Dr. C. Michael Gibson discuss: A Prospective, Randomized,
Investigation of a Novel Platinum Chromium EverolimusEluting Coronary Stent: The PLATINUM
Trial at ACC 2011.
G.W. Stone: Scientific advisory boards for and honoraria from Boston Scientific and Abbott
Vascular, and consultant to Medtronic. IT Meredith: Scientific advisory boards for and
honoraria from Boston Scientific. P.S. Teirstein: Research grants, honoraria, and
consulting fees from Boston Scientific, Abbott, Cordis and Medtronic. B. Farah: Honoraria
from Boston Scientific and Abbott Vascular. C.L. Dubois: Honoraria from Boston Scientific
and Abbott Vascular. T.L. Feldman: Scientific advisory board for and honoraria from Boston
Scientific. J. Dens: None. N. Hagiwara: None. D.L. Allocco: Full-time employee and
stockholder of Boston Scientific. K.D. Dawkins: Full-time employee and stockholder of
Boston Scientific.
[ Download video ] |
|
No comments have been submitted
|